These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 6084807)
1. [Analysis of specific tumor antigens in mice and human neuroblastoma]. Etoh T Nihon Geka Gakkai Zasshi; 1984 Dec; 85(12):1579-85. PubMed ID: 6084807 [TBL] [Abstract][Full Text] [Related]
2. Studies on the induction and expression of T cell-mediated immunity. XV. Role of non-MHC papain-sensitive target structures and Lyt-2 antigens in allogeneic and xenogeneic lectin-dependent cellular cytotoxicity (LDCC). Bonavida B; Katz J J Immunol; 1985 Sep; 135(3):1616-23. PubMed ID: 3874903 [TBL] [Abstract][Full Text] [Related]
3. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. de Vries JE; Spits H J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458 [TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype. Lynch DH; Daynes RA; Hodes RJ J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117 [TBL] [Abstract][Full Text] [Related]
5. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones. Yannelli JR; Moore LC; Engelhard VH J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157 [TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice. Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223 [TBL] [Abstract][Full Text] [Related]
7. Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: immunotherapeutic implications. Morandi F; Chiesa S; Bocca P; Millo E; Salis A; Solari M; Pistoia V; Prigione I Neoplasia; 2006 Oct; 8(10):833-42. PubMed ID: 17032500 [TBL] [Abstract][Full Text] [Related]
8. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro. Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374 [TBL] [Abstract][Full Text] [Related]
9. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo. Hostetler LW; Romerdahl CA; Kripke ML Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081 [TBL] [Abstract][Full Text] [Related]
10. Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes. Sarkar AK; Nuchtern JG Cancer Res; 2000 Apr; 60(7):1908-13. PubMed ID: 10766179 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T cell clones against human autologous cancers: analysis of target antigen and the mechanism of specific target cell destruction. Kikuchi K; Okubo M; Sato T; Sato N Princess Takamatsu Symp; 1988; 19():303-13. PubMed ID: 3269362 [TBL] [Abstract][Full Text] [Related]
12. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level. Sensi M; Orosz CG; Bach FH J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778 [TBL] [Abstract][Full Text] [Related]
13. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells. Plata F; Jongeneel V; Cerottini JC; Brunner KT Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429 [TBL] [Abstract][Full Text] [Related]
14. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes. Tremblay N; Fontaine P; Perreault C Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709 [TBL] [Abstract][Full Text] [Related]
15. Studies on the induction and expression of T cell-mediated immunity. XIV. Antigen-nonspecific oxidation-dependent cellular cytotoxicity (ODCC) mediated by sodium periodate oxidation of cytotoxic T lymphocytes. Fan J; Bonavida B J Immunol; 1983 Sep; 131(3):1426-32. PubMed ID: 6193189 [TBL] [Abstract][Full Text] [Related]
16. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays. Lopez PF; Parks WP; Lopez DM J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544 [TBL] [Abstract][Full Text] [Related]
17. Degradation of specificity in cytolytic T lymphocyte clones: two broad specificity, H-2-independent recognition systems, one natural killer-like, develop during culture, in addition to the clonally distributed antigen-specific receptor. Wilson A; Shortman K Eur J Immunol; 1985 Sep; 15(9):899-905. PubMed ID: 2412835 [TBL] [Abstract][Full Text] [Related]
18. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis. Tomkinson BE; Maziarz R; Sullivan JL J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449 [TBL] [Abstract][Full Text] [Related]
19. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma. Fukuda M; Nozaki C; Ishiguro Y; Horibe K Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870 [TBL] [Abstract][Full Text] [Related]
20. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways. Singer A; Kruisbeek AM; Andrysiak PM J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]